Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

The implantation of bioprosthetic heart valves (BHVs) is increasingly becoming the treatment
of choice in patients requiring heart valve replacement surgery. Unlike mechanical heart …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Background In low surgical risk patients with symptomatic severe aortic stenosis, the
PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low …

Background Among patients with aortic stenosis who are at intermediate or high risk for
death with surgery, major outcomes are similar with transcatheter aortic-valve replacement …

Background It is unknown whether transcatheter valves will have similar durability as
surgical bioprosthetic valves. Definitions of structural valve deterioration (SVD), based on …

Background Transcatheter aortic valve replacement (TAVR) use is increasing in patients
with longer life expectancy, yet robust data on the durability of transcatheter heart valves …

Importance The frequency and clinical importance of structural valve deterioration (SVD) in
patients undergoing self-expanding transcatheter aortic valve implantation (TAVI) or surgery …

Aims Due to bioprosthetic valve degeneration, aortic valve-in-valve (ViV) procedures are
increasingly performed. There are no data on long-term outcomes after aortic ViV. Our aim …